Contact Us

ViroGates’ Global Growth: Introducing New Leadership for Expanded Success

Wed Aug 14 2019

ViroGates proudly welcomes two new key players to its team, enhancing its global outreach and financial leadership.

Joining on August 1, Thomas Brydensholt steps into the role of Global Partner Director. Formerly at Getinge, Thomas spearheaded the Business Development Team in DACH, later driving the EMEA business strategy for Getinge’s Health Care Division. Armed with a PhD in Sales & Marketing from Copenhagen Business School (CBS), Thomas now focuses on ViroGates’ indirect sales to the acute care segment through distributors in untapped territories.

Mark Christian Hvidberg da Silva, aged 29, assumes the position of CFO starting October 1. Mark, was previously a Manager at QVARTZ, brings expertise from managing diverse client projects in corporate strategy, go-to-market strategy, and commercial excellence. His prior experience spans Novozymes in Denmark and Nova Founders Capital in Malaysia and the Philippines. With an M.Sc. in Economics and Business Administration (International Business) from CBS, Mark will lead ViroGates’ CFO function, emphasizing strategy execution, reporting, finance, and investor relations. This transition sees May Britt Dyvelkov, the outgoing CFO, taking on a new role as Vice President of Accounting.

Thomas and Mark’s appointments mark a strategic move for ViroGates, enhancing its leadership team with professionals boasting a wealth of experience. Their roles extend beyond traditional boundaries, contributing significantly to the company’s growth and global presence. As they embark on their journeys with ViroGates, the entire team extends its best wishes, anticipating continued success and fruitful collaboration. May the synergy between existing expertise and fresh perspectives propel ViroGates to new heights in the global market.

Read 1000+ published suPAR studies in leading medical journals

suPAR and inflammation in Nature Medicine medical and scientific Journal
suPAR and inflammation in The New England Journal of Medicine
suPAR and inflammation in Science AAAS Journal
suPAR and inflammation in JAMA medical and scientific journal

Company

  • About ViroGates
  • Management
  • Employees
  • Board
Privacy PolicyTerms of ServiceCookie Policy

© 2026 ViroGates. All rights reserved.

suPARnostic® by ViroGates